Bayer CropScience Ltd Q4 FY26 Results Analysis: Margin Expands 280 bps, Material Costs Plunge 12%

Bayer CropScience Ltd's Q4 FY26 numbers came in strong, with revenue of Rs. 5,675.00 Cr (+3.70% YoY) and PAT growth of +21.40% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quarter Snapshot

FY26 showed margin expansion (280 bps) and strong cash conversion despite moderate revenue growth of 3.7%. Cost management was excellent with material costs declining 12.1%, but trade receivables growing 17.2% warrants monitoring. No specific India guidance was provided against which to assess beats.

Key Investment Insights

Key Positives

• FY26 EBITDA margin expanded 280 bps YoY to 15.4% from 12.6%, driven by 12.1% reduction in material costs and 2.6% cut in employee expenses.
• FY26 PAT grew 21.4% YoY to Rs.6,892M on revenue growth of 3.7%, demonstrating operating leverage.
• FY26 operating cash flow of Rs.10,785M was 1.56x PAT, indicating high earnings quality.
• Working capital swung to a cash release of Rs.3,006M in FY26 from a cash use of Rs.3,651M in FY25.
• DEKALB corn retained #1 market position for the 3rd consecutive year.
• ROE improved 370 bps YoY to 23.6% in FY26.

Risk Factors

• Trade receivables grew 17.2% YoY in FY26, far outpacing revenue growth of 3.7%, signaling potential collection pressure.
• Revenue growth moderated to 3.7% in FY26 from 7% in FY25.
• Three regulatory penalty orders totaling Rs.41.86M were received in Q4 FY26 for GST/E-way bill compliance issues.
• The quarterly EBITDA margin of 18.4% in Q4 was partly boosted by inventory capitalization of Rs.3,677M, which may not recur.